Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 118 | 2024 | 3788 | 8.590 |
Why?
|
Antirheumatic Agents | 39 | 2023 | 1383 | 3.550 |
Why?
|
Aneurysm, Ruptured | 14 | 2021 | 455 | 1.570 |
Why?
|
Intracranial Aneurysm | 18 | 2024 | 1271 | 1.490 |
Why?
|
Lyme Disease | 12 | 2016 | 627 | 1.390 |
Why?
|
Severity of Illness Index | 45 | 2023 | 15912 | 1.200 |
Why?
|
Lung Diseases, Interstitial | 12 | 2024 | 940 | 1.200 |
Why?
|
Registries | 23 | 2023 | 8352 | 1.160 |
Why?
|
Hand Joints | 2 | 2023 | 58 | 0.910 |
Why?
|
Biological Products | 3 | 2023 | 948 | 0.780 |
Why?
|
Fibromyalgia | 3 | 2022 | 407 | 0.760 |
Why?
|
Tumor Necrosis Factor-alpha | 14 | 2017 | 4349 | 0.750 |
Why?
|
Psychological Techniques | 1 | 2018 | 48 | 0.620 |
Why?
|
Disease Progression | 19 | 2023 | 13642 | 0.570 |
Why?
|
Rheumatoid Factor | 9 | 2019 | 185 | 0.560 |
Why?
|
Methotrexate | 9 | 2023 | 1719 | 0.550 |
Why?
|
Diagnostic Self Evaluation | 2 | 2017 | 228 | 0.530 |
Why?
|
Peptides, Cyclic | 8 | 2019 | 390 | 0.480 |
Why?
|
Middle Aged | 110 | 2024 | 223267 | 0.460 |
Why?
|
C-Reactive Protein | 11 | 2021 | 3853 | 0.450 |
Why?
|
Bronchiectasis | 3 | 2022 | 141 | 0.450 |
Why?
|
Low Back Pain | 1 | 2022 | 986 | 0.440 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2019 | 1023 | 0.440 |
Why?
|
Aged | 88 | 2024 | 171344 | 0.440 |
Why?
|
Female | 126 | 2024 | 396532 | 0.420 |
Why?
|
Peer Group | 1 | 2018 | 702 | 0.410 |
Why?
|
Self Efficacy | 2 | 2013 | 643 | 0.400 |
Why?
|
Autoantibodies | 9 | 2022 | 2115 | 0.380 |
Why?
|
Health Education | 2 | 2016 | 1060 | 0.370 |
Why?
|
Humans | 164 | 2024 | 766812 | 0.370 |
Why?
|
Patient Dropouts | 1 | 2013 | 411 | 0.360 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 50 | 0.360 |
Why?
|
Male | 107 | 2024 | 364154 | 0.350 |
Why?
|
Health Behavior | 6 | 2016 | 2649 | 0.350 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1884 | 0.340 |
Why?
|
Rheumatology | 5 | 2022 | 619 | 0.340 |
Why?
|
Basilar Artery | 2 | 2021 | 207 | 0.330 |
Why?
|
Prospective Studies | 33 | 2023 | 54872 | 0.330 |
Why?
|
Smoking | 6 | 2024 | 9077 | 0.320 |
Why?
|
Health Status | 11 | 2021 | 4087 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2017 | 4056 | 0.310 |
Why?
|
Patient Education as Topic | 2 | 2018 | 2334 | 0.310 |
Why?
|
Education, Distance | 2 | 2022 | 260 | 0.300 |
Why?
|
Adult | 67 | 2024 | 223305 | 0.300 |
Why?
|
Bone Density | 4 | 2018 | 3491 | 0.300 |
Why?
|
Troponin T | 2 | 2024 | 786 | 0.290 |
Why?
|
HLA-DR4 Antigen | 1 | 2007 | 22 | 0.290 |
Why?
|
Schools | 1 | 2016 | 1496 | 0.280 |
Why?
|
Antibodies, Monoclonal | 7 | 2016 | 9244 | 0.280 |
Why?
|
Fatigue | 5 | 2022 | 1555 | 0.280 |
Why?
|
Physical Therapy Modalities | 1 | 2010 | 533 | 0.280 |
Why?
|
Borrelia burgdorferi | 1 | 2008 | 183 | 0.270 |
Why?
|
Exercise | 3 | 2017 | 5945 | 0.270 |
Why?
|
Cohort Studies | 30 | 2019 | 41706 | 0.270 |
Why?
|
Circle of Willis | 3 | 2021 | 77 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 13 | 2016 | 18076 | 0.260 |
Why?
|
Attitude to Health | 2 | 2016 | 2021 | 0.260 |
Why?
|
Office Visits | 1 | 2010 | 593 | 0.260 |
Why?
|
Alcohol Drinking | 3 | 2017 | 4045 | 0.250 |
Why?
|
Ticks | 4 | 2016 | 71 | 0.250 |
Why?
|
Multivariate Analysis | 12 | 2020 | 12064 | 0.250 |
Why?
|
Medical Records | 2 | 2010 | 1408 | 0.250 |
Why?
|
Risk Factors | 34 | 2024 | 74889 | 0.240 |
Why?
|
Pregnancy Complications | 2 | 2017 | 2971 | 0.230 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1263 | 0.230 |
Why?
|
Psychotherapy | 1 | 2013 | 1648 | 0.230 |
Why?
|
Interferon-alpha | 2 | 2021 | 910 | 0.230 |
Why?
|
Arthrography | 3 | 2014 | 149 | 0.220 |
Why?
|
Health Promotion | 3 | 2016 | 2209 | 0.220 |
Why?
|
Aspirin | 2 | 2018 | 3134 | 0.220 |
Why?
|
Boston | 5 | 2021 | 9346 | 0.210 |
Why?
|
Immunologic Factors | 3 | 2023 | 1594 | 0.210 |
Why?
|
Treatment Outcome | 21 | 2021 | 65286 | 0.210 |
Why?
|
Lyme Disease Vaccines | 2 | 2007 | 18 | 0.200 |
Why?
|
Time Factors | 16 | 2021 | 40149 | 0.200 |
Why?
|
Finger Joint | 1 | 2023 | 108 | 0.200 |
Why?
|
Case-Control Studies | 20 | 2024 | 22248 | 0.200 |
Why?
|
Emigrants and Immigrants | 1 | 2008 | 550 | 0.190 |
Why?
|
Disability Evaluation | 7 | 2016 | 1828 | 0.190 |
Why?
|
Caffeine | 1 | 2006 | 702 | 0.190 |
Why?
|
Radiography | 7 | 2023 | 6968 | 0.190 |
Why?
|
Anti-Inflammatory Agents | 2 | 2010 | 1805 | 0.190 |
Why?
|
Borrelia burgdorferi Group | 2 | 2000 | 95 | 0.190 |
Why?
|
Logistic Models | 12 | 2022 | 13276 | 0.190 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 26309 | 0.190 |
Why?
|
Musculoskeletal Diseases | 2 | 1999 | 598 | 0.190 |
Why?
|
Wrist Joint | 1 | 2023 | 266 | 0.180 |
Why?
|
Odds Ratio | 7 | 2022 | 9661 | 0.180 |
Why?
|
Babesia | 1 | 2000 | 29 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 15 | 2019 | 16044 | 0.180 |
Why?
|
Sex Factors | 7 | 2024 | 10619 | 0.180 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 271 | 0.170 |
Why?
|
Age Factors | 9 | 2021 | 18397 | 0.170 |
Why?
|
Emphysema | 1 | 2022 | 234 | 0.170 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2012 | 64 | 0.170 |
Why?
|
Herpesvirus 8, Human | 1 | 2021 | 254 | 0.170 |
Why?
|
Babesiosis | 1 | 2000 | 92 | 0.170 |
Why?
|
STAT1 Transcription Factor | 1 | 2021 | 340 | 0.160 |
Why?
|
Polysaccharides | 3 | 2012 | 1020 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2023 | 609 | 0.160 |
Why?
|
Principal Component Analysis | 2 | 2021 | 949 | 0.160 |
Why?
|
Databases, Factual | 4 | 2020 | 8065 | 0.160 |
Why?
|
Remission Induction | 7 | 2020 | 2413 | 0.150 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2013 | 588 | 0.150 |
Why?
|
Data Mining | 2 | 2021 | 560 | 0.150 |
Why?
|
Central Nervous System Stimulants | 1 | 2006 | 1168 | 0.140 |
Why?
|
Pain Measurement | 4 | 2017 | 3576 | 0.140 |
Why?
|
Lead Poisoning | 1 | 2000 | 323 | 0.140 |
Why?
|
Confidence Intervals | 4 | 2014 | 2921 | 0.140 |
Why?
|
Prednisolone | 1 | 2018 | 326 | 0.140 |
Why?
|
Massachusetts | 6 | 2016 | 8890 | 0.140 |
Why?
|
Perception | 2 | 2017 | 1204 | 0.140 |
Why?
|
Hemoglobins | 1 | 2023 | 1531 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 3 | 2021 | 1852 | 0.140 |
Why?
|
Nervous System Diseases | 2 | 1999 | 1659 | 0.140 |
Why?
|
Tick Infestations | 1 | 2016 | 9 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 173 | 0.140 |
Why?
|
Linear Models | 5 | 2019 | 5873 | 0.140 |
Why?
|
Patient-Centered Care | 1 | 2007 | 1445 | 0.130 |
Why?
|
Glucocorticoids | 3 | 2019 | 2158 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2018 | 382 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3230 | 0.130 |
Why?
|
Heart Diseases | 2 | 2021 | 2817 | 0.130 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 872 | 0.130 |
Why?
|
Prognosis | 13 | 2021 | 29959 | 0.130 |
Why?
|
Recovery of Function | 1 | 2007 | 2978 | 0.130 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 520 | 0.130 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 657 | 0.130 |
Why?
|
Longitudinal Studies | 8 | 2017 | 14762 | 0.130 |
Why?
|
Nurse's Role | 1 | 2017 | 187 | 0.130 |
Why?
|
Immunoglobulin G | 4 | 2013 | 4559 | 0.130 |
Why?
|
Joints | 2 | 2014 | 324 | 0.120 |
Why?
|
Follow-Up Studies | 13 | 2019 | 39312 | 0.120 |
Why?
|
Interleukin-10 | 1 | 2021 | 1182 | 0.120 |
Why?
|
Risk Assessment | 5 | 2024 | 24299 | 0.120 |
Why?
|
Aneurysm | 1 | 2018 | 343 | 0.120 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2021 | 1750 | 0.120 |
Why?
|
Aged, 80 and over | 11 | 2024 | 59548 | 0.120 |
Why?
|
Lung Transplantation | 1 | 2024 | 1310 | 0.120 |
Why?
|
Magnesium | 1 | 2018 | 815 | 0.120 |
Why?
|
Lead | 1 | 2000 | 882 | 0.110 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3485 | 0.110 |
Why?
|
Efficiency | 1 | 2017 | 479 | 0.110 |
Why?
|
Cholesterol, LDL | 2 | 2021 | 2392 | 0.110 |
Why?
|
Uric Acid | 1 | 2000 | 809 | 0.110 |
Why?
|
Hematologic Tests | 1 | 2015 | 239 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2021 | 2721 | 0.110 |
Why?
|
Quality of Life | 7 | 2016 | 13476 | 0.110 |
Why?
|
Primary Prevention | 3 | 2010 | 1188 | 0.110 |
Why?
|
Algorithms | 6 | 2019 | 14073 | 0.110 |
Why?
|
Interferon-beta | 1 | 2015 | 348 | 0.110 |
Why?
|
Pain | 3 | 2019 | 5098 | 0.110 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2021 | 347 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 832 | 0.110 |
Why?
|
Radiographic Image Enhancement | 1 | 2018 | 873 | 0.110 |
Why?
|
Gout | 1 | 2000 | 622 | 0.110 |
Why?
|
Inflammation | 4 | 2021 | 10863 | 0.100 |
Why?
|
Proportional Hazards Models | 5 | 2019 | 12536 | 0.100 |
Why?
|
Life Style | 3 | 2022 | 3926 | 0.100 |
Why?
|
Risk | 4 | 2020 | 9602 | 0.100 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7841 | 0.100 |
Why?
|
Genome-Wide Association Study | 5 | 2019 | 12808 | 0.100 |
Why?
|
Phenotype | 5 | 2021 | 16722 | 0.100 |
Why?
|
Sjogren's Syndrome | 1 | 2014 | 240 | 0.100 |
Why?
|
School Health Services | 1 | 2016 | 388 | 0.100 |
Why?
|
Arthralgia | 2 | 2011 | 459 | 0.100 |
Why?
|
Retrospective Studies | 15 | 2024 | 81657 | 0.100 |
Why?
|
Self Report | 4 | 2017 | 3771 | 0.100 |
Why?
|
Reproducibility of Results | 7 | 2019 | 20146 | 0.100 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 161 | 0.100 |
Why?
|
Anaphylaxis | 1 | 1999 | 738 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2018 | 10745 | 0.100 |
Why?
|
Natural Language Processing | 2 | 2020 | 1203 | 0.100 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1814 | 0.090 |
Why?
|
Respiratory Function Tests | 4 | 2019 | 1691 | 0.090 |
Why?
|
Self Care | 2 | 2013 | 800 | 0.090 |
Why?
|
Peptide Fragments | 2 | 2021 | 5143 | 0.090 |
Why?
|
Employment | 1 | 2017 | 1110 | 0.090 |
Why?
|
Physical Examination | 2 | 2013 | 1265 | 0.090 |
Why?
|
Antibodies, Heterophile | 1 | 2011 | 128 | 0.090 |
Why?
|
Models, Econometric | 2 | 2008 | 215 | 0.090 |
Why?
|
Arthritis | 1 | 2016 | 684 | 0.090 |
Why?
|
Galactose | 1 | 2012 | 299 | 0.090 |
Why?
|
Postmenopause | 2 | 2018 | 2517 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1812 | 0.090 |
Why?
|
Immunoconjugates | 2 | 2008 | 976 | 0.090 |
Why?
|
Predictive Value of Tests | 8 | 2019 | 15425 | 0.090 |
Why?
|
Asthma | 1 | 2009 | 6266 | 0.090 |
Why?
|
HLA-DR Antigens | 3 | 2009 | 609 | 0.090 |
Why?
|
Interleukin-6 | 3 | 2021 | 3226 | 0.090 |
Why?
|
Incidence | 5 | 2021 | 21527 | 0.090 |
Why?
|
Immunoglobulin E | 1 | 1996 | 1495 | 0.080 |
Why?
|
Alleles | 4 | 2013 | 6896 | 0.080 |
Why?
|
Focus Groups | 1 | 2016 | 1459 | 0.080 |
Why?
|
Warfarin | 1 | 2018 | 1493 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2504 | 0.080 |
Why?
|
Antigens, CD | 2 | 2013 | 4033 | 0.080 |
Why?
|
Endemic Diseases | 2 | 2023 | 190 | 0.080 |
Why?
|
Health Resources | 1 | 2016 | 950 | 0.080 |
Why?
|
Nucleotide Deaminases | 1 | 2009 | 11 | 0.080 |
Why?
|
Hydroxymethyl and Formyl Transferases | 1 | 2009 | 18 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 331 | 0.080 |
Why?
|
Forced Expiratory Volume | 1 | 2014 | 1828 | 0.080 |
Why?
|
Adiposity | 1 | 2019 | 1892 | 0.080 |
Why?
|
Lung Diseases | 1 | 2019 | 1940 | 0.080 |
Why?
|
Metacarpal Bones | 1 | 2009 | 77 | 0.080 |
Why?
|
RANK Ligand | 1 | 2010 | 321 | 0.080 |
Why?
|
Social Marketing | 1 | 2008 | 51 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 4 | 2015 | 1740 | 0.080 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 11924 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2908 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4765 | 0.070 |
Why?
|
Interleukin-1alpha | 1 | 2008 | 88 | 0.070 |
Why?
|
Disease Management | 2 | 2015 | 2533 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2662 | 0.070 |
Why?
|
Connective Tissue Diseases | 1 | 2010 | 285 | 0.070 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15652 | 0.070 |
Why?
|
Immunoassay | 1 | 2011 | 744 | 0.070 |
Why?
|
Prevalence | 6 | 2021 | 15835 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2018 | 5306 | 0.070 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2007 | 103 | 0.070 |
Why?
|
Medicare | 2 | 2016 | 6813 | 0.070 |
Why?
|
Acculturation | 1 | 2008 | 179 | 0.070 |
Why?
|
Alternative Splicing | 1 | 2012 | 1103 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2016 | 14653 | 0.070 |
Why?
|
Breast Implants | 1 | 2010 | 414 | 0.070 |
Why?
|
Complementarity Determining Regions | 1 | 2007 | 154 | 0.070 |
Why?
|
Serum | 1 | 2007 | 206 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2008 | 437 | 0.070 |
Why?
|
Environmental Exposure | 2 | 2007 | 4544 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2007 | 370 | 0.070 |
Why?
|
Diet | 3 | 2017 | 8088 | 0.070 |
Why?
|
Adolescent | 7 | 2021 | 88902 | 0.060 |
Why?
|
Comorbidity | 3 | 2015 | 10580 | 0.060 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2009 | 399 | 0.060 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5795 | 0.060 |
Why?
|
Educational Status | 1 | 2013 | 2510 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6514 | 0.060 |
Why?
|
Bone Diseases | 1 | 2009 | 412 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2085 | 0.060 |
Why?
|
Multienzyme Complexes | 1 | 2009 | 663 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3208 | 0.060 |
Why?
|
Histocompatibility Testing | 1 | 2007 | 726 | 0.060 |
Why?
|
Antibodies | 2 | 2014 | 2421 | 0.060 |
Why?
|
Haplotypes | 2 | 2008 | 2726 | 0.060 |
Why?
|
Calcium | 1 | 2018 | 5783 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4252 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3108 | 0.060 |
Why?
|
Respiratory Sounds | 1 | 2009 | 702 | 0.060 |
Why?
|
Gene Dosage | 1 | 2009 | 1211 | 0.060 |
Why?
|
Culture | 1 | 2008 | 622 | 0.060 |
Why?
|
Lung | 3 | 2022 | 10068 | 0.060 |
Why?
|
Antigens, Differentiation | 1 | 2007 | 921 | 0.060 |
Why?
|
Brazil | 1 | 2008 | 1250 | 0.060 |
Why?
|
Vitamin E | 1 | 2008 | 872 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3111 | 0.060 |
Why?
|
Genetic Variation | 2 | 2009 | 6613 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2007 | 1529 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2694 | 0.060 |
Why?
|
Withholding Treatment | 1 | 2008 | 619 | 0.060 |
Why?
|
Young Adult | 3 | 2021 | 59939 | 0.060 |
Why?
|
Tetralogy of Fallot | 1 | 2009 | 628 | 0.060 |
Why?
|
Research Design | 2 | 2018 | 6206 | 0.050 |
Why?
|
Genotype | 5 | 2010 | 13036 | 0.050 |
Why?
|
Electronic Health Records | 3 | 2019 | 4880 | 0.050 |
Why?
|
United States | 10 | 2022 | 72945 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6020 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 3 | 2021 | 4047 | 0.050 |
Why?
|
Mental Health | 1 | 2017 | 3269 | 0.050 |
Why?
|
Medication Adherence | 1 | 2014 | 2190 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2010 | 1404 | 0.050 |
Why?
|
Anticoagulants | 1 | 2018 | 4854 | 0.050 |
Why?
|
Urban Population | 1 | 2010 | 2040 | 0.050 |
Why?
|
Mutation | 1 | 2007 | 30214 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2429 | 0.050 |
Why?
|
Health Surveys | 3 | 2017 | 4055 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2008 | 1026 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 2039 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
ROC Curve | 3 | 2015 | 3621 | 0.050 |
Why?
|
Area Under Curve | 2 | 2016 | 1639 | 0.050 |
Why?
|
Drug Interactions | 1 | 2006 | 1419 | 0.050 |
Why?
|
Motor Activity | 2 | 2015 | 2711 | 0.050 |
Why?
|
Vital Capacity | 1 | 2024 | 995 | 0.050 |
Why?
|
Regression Analysis | 3 | 2015 | 6329 | 0.050 |
Why?
|
Cost-Benefit Analysis | 4 | 2015 | 5536 | 0.050 |
Why?
|
Signal Transduction | 2 | 2021 | 23618 | 0.050 |
Why?
|
Observer Variation | 1 | 2007 | 2614 | 0.040 |
Why?
|
Genetic Loci | 1 | 2010 | 2631 | 0.040 |
Why?
|
Antioxidants | 1 | 2008 | 1671 | 0.040 |
Why?
|
Epitopes | 1 | 2007 | 2526 | 0.040 |
Why?
|
Propensity Score | 2 | 2018 | 1972 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2023 | 537 | 0.040 |
Why?
|
Rural Population | 1 | 2010 | 2321 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2021 | 305 | 0.040 |
Why?
|
Isoxazoles | 1 | 2001 | 233 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2021 | 385 | 0.040 |
Why?
|
Aortic Aneurysm | 1 | 2024 | 649 | 0.040 |
Why?
|
Pregnancy | 2 | 2017 | 30236 | 0.040 |
Why?
|
Data Collection | 1 | 2008 | 3321 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13489 | 0.040 |
Why?
|
Histamine H1 Antagonists | 1 | 1999 | 100 | 0.040 |
Why?
|
Chemokines | 2 | 2015 | 963 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2008 | 1761 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2009 | 2979 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2013 | 2662 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 10 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
Models, Statistical | 1 | 2013 | 5092 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
Decision Support Techniques | 2 | 2015 | 2007 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3915 | 0.040 |
Why?
|
Public Health | 2 | 2008 | 2680 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3803 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 588 | 0.040 |
Why?
|
Chronic Disease | 3 | 2017 | 9358 | 0.040 |
Why?
|
Adrenergic beta-Agonists | 1 | 1999 | 345 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 365 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2022 | 642 | 0.040 |
Why?
|
Telomere | 1 | 2024 | 943 | 0.040 |
Why?
|
Amoxicillin | 1 | 1998 | 179 | 0.040 |
Why?
|
Aging | 1 | 1996 | 8728 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1641 | 0.030 |
Why?
|
Animals | 6 | 2016 | 168939 | 0.030 |
Why?
|
Republic of Korea | 1 | 2019 | 591 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2018 | 2160 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2008 | 1880 | 0.030 |
Why?
|
Down-Regulation | 2 | 2018 | 2931 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 601 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 10384 | 0.030 |
Why?
|
Epinephrine | 1 | 1999 | 782 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9464 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2262 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20710 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 49 | 0.030 |
Why?
|
Penicillins | 1 | 1998 | 404 | 0.030 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2015 | 60 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2001 | 1667 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2018 | 561 | 0.030 |
Why?
|
Silver Staining | 1 | 1994 | 63 | 0.030 |
Why?
|
Up-Regulation | 2 | 2018 | 4143 | 0.030 |
Why?
|
Mental Disorders | 1 | 1994 | 6869 | 0.030 |
Why?
|
Creatinine | 1 | 2000 | 1917 | 0.030 |
Why?
|
Confidentiality | 1 | 2019 | 607 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10263 | 0.030 |
Why?
|
HLA-DR3 Antigen | 1 | 2014 | 24 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1606 | 0.030 |
Why?
|
Pseudomonas | 1 | 1994 | 124 | 0.030 |
Why?
|
Haemophilus influenzae | 1 | 1994 | 177 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2021 | 8928 | 0.030 |
Why?
|
Diet Surveys | 1 | 2017 | 1159 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2007 | 3266 | 0.030 |
Why?
|
Software | 1 | 2007 | 4464 | 0.030 |
Why?
|
Administration, Oral | 2 | 2018 | 4019 | 0.030 |
Why?
|
Triglycerides | 1 | 2021 | 2441 | 0.030 |
Why?
|
Child | 3 | 2016 | 80670 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22350 | 0.030 |
Why?
|
Hip Joint | 2 | 2009 | 1017 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 862 | 0.030 |
Why?
|
Memory Disorders | 1 | 1999 | 1193 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2014 | 472 | 0.020 |
Why?
|
Cholesterol | 1 | 2021 | 2904 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3213 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 13050 | 0.020 |
Why?
|
Risk-Taking | 1 | 1997 | 1022 | 0.020 |
Why?
|
Sputum | 1 | 1994 | 514 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1998 | 2350 | 0.020 |
Why?
|
Vaginal Smears | 1 | 2014 | 505 | 0.020 |
Why?
|
Food Hypersensitivity | 1 | 1999 | 734 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 2270 | 0.020 |
Why?
|
Leptin | 1 | 2019 | 1596 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2016 | 935 | 0.020 |
Why?
|
SOXD Transcription Factors | 1 | 2010 | 44 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2353 | 0.020 |
Why?
|
Genomics | 1 | 2006 | 5922 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 713 | 0.020 |
Why?
|
Genome, Human | 3 | 2008 | 4443 | 0.020 |
Why?
|
Population Surveillance | 1 | 2000 | 2594 | 0.020 |
Why?
|
Steroids | 1 | 2015 | 936 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2009 | 3702 | 0.020 |
Why?
|
Drug Costs | 2 | 2008 | 1194 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2014 | 4215 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8310 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 874 | 0.020 |
Why?
|
Weight Loss | 1 | 2001 | 2712 | 0.020 |
Why?
|
Recurrence | 2 | 2018 | 8507 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2014 | 1996 | 0.020 |
Why?
|
Health Care Costs | 2 | 2015 | 3240 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2012 | 1989 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 668 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2009 | 322 | 0.020 |
Why?
|
Complement C3a | 1 | 1988 | 66 | 0.020 |
Why?
|
Electrocardiography | 2 | 1998 | 6408 | 0.020 |
Why?
|
Blotting, Western | 2 | 2012 | 5022 | 0.020 |
Why?
|
Transcobalamins | 1 | 1987 | 22 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2826 | 0.020 |
Why?
|
Glycoside Hydrolases | 1 | 2007 | 135 | 0.020 |
Why?
|
Disease Vectors | 1 | 2007 | 61 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 1992 | 1130 | 0.020 |
Why?
|
Receptors, Complement | 1 | 1988 | 254 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2783 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1716 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2009 | 640 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2009 | 880 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 1994 | 1429 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2008 | 592 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2016 | 2233 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2006 | 203 | 0.020 |
Why?
|
Child, Preschool | 3 | 2009 | 42577 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1326 | 0.010 |
Why?
|
Morbidity | 1 | 2010 | 1754 | 0.010 |
Why?
|
Psychometrics | 1 | 1994 | 3060 | 0.010 |
Why?
|
Blood Pressure | 1 | 2000 | 8533 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1987 | 531 | 0.010 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2008 | 878 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1804 | 0.010 |
Why?
|
Hand | 1 | 2009 | 910 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1434 | 0.010 |
Why?
|
Models, Genetic | 1 | 2014 | 3446 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1707 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1276 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3430 | 0.010 |
Why?
|
Age of Onset | 1 | 2010 | 3343 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2342 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3250 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2012 | 2591 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3431 | 0.010 |
Why?
|
Spine | 1 | 2009 | 1134 | 0.010 |
Why?
|
Treatment Failure | 1 | 2008 | 2659 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8734 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5502 | 0.010 |
Why?
|
Autoimmunity | 1 | 2009 | 1361 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7585 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 1878 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4618 | 0.010 |
Why?
|
Genetic Markers | 1 | 2006 | 2603 | 0.010 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 1196 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2007 | 987 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 2001 | 501 | 0.010 |
Why?
|
Infant | 1 | 2001 | 36459 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2014 | 4306 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9326 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7430 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6306 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2009 | 3831 | 0.010 |
Why?
|
Fractures, Bone | 1 | 2009 | 2043 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9528 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1998 | 1377 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7438 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12795 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 17089 | 0.010 |
Why?
|
Neutrophils | 1 | 1988 | 3782 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12430 | 0.010 |
Why?
|
Child Behavior | 1 | 1998 | 864 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 1998 | 1477 | 0.010 |
Why?
|
Reference Values | 1 | 1998 | 4914 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1729 | 0.010 |
Why?
|
Receptors, Complement 3b | 1 | 1988 | 136 | 0.000 |
Why?
|
Complement C3 | 1 | 1988 | 434 | 0.000 |
Why?
|